RESUMEN
The co-application of biosolids and water treatment residuals (WTRs) has been previously trialed to reduce excessive bioavailable P in the soil treated with biosolids. However, uncertainty still exists regarding the environmental consequences of the co-application of biosolids and WTRs, especially in alkaline soils in Egypt or the Middle East region. A greenhouse pot study was conducted with Egyptian alkaline soils to (i) quantify the effects of co-application of biosolids and drinking WTRs on biomass production of corn (Zea mays L. cultivar single hybrid 10), (ii) determine the co-application effects on Olsen-P and KCl-extractable Al in relation to their accumulation in plant tissues, and (iii) optimize the co-application ratio of biosolids to WTRs for the best yield and effective reduction of soil bioavailable P. The results show that, among the studied soils treated with 1% biosolids along with various rates of WTRs, the corn yield increased significantly (P < 0.01) with increasing WTR application rate from 0 to 3% (w/w), but decreased at 4% application rate. The corn yield also significantly correlated with soil water holding capacity that increased with the addition of WTRs. Phosphorus uptake by plants significantly (P < 0.01) increased when the biosolid application rate was increased from 1 to 3% in the three studied soils that were treated with 1, 2, or 3% WTRs. The application of 4% WTRs in the biosolid-amended soils resulted in a significant reduction in soil Olsen-P values, but without having observable phytotoxicity of metals (such as Al) to corn during the growth period. The effective co-application ratio of biosolids to WTRs, for increasing corn yield and minimizing the potential for bioavailable P in runoff, was approximately 1:1 at the application rate of 3% biosolids and 4% WTRs in the alkaline soils.
Asunto(s)
Álcalis , Aluminio/análisis , Fósforo/análisis , Aguas del Alcantarillado , Suelo , Zea mays/crecimiento & desarrollo , Aluminio/farmacocinética , Disponibilidad Biológica , Biomasa , Egipto , Fósforo/farmacocinéticaRESUMEN
This study was performed to evaluate the role of Aloe vera (Aloe barbadensis Miller) on the antioxidant status in different tissues of animals whole body exposed to 7 Gy gamma radiations, delivered as a shot dose. Aloe vera (leaf juice filtrate) was supplemented daily to rats (0.25 ml/kg body weight/day), by gavage, 5 days before irradiation and 10 days after irradiation. Experimental investigations performed 3, 7 and 10 days after exposure to radiation showed that Aloe vera treatment has significantly minimized the radiation-induced increase in the amount of malondialdehyde in liver, lungs, and kidney tissues of irradiated rats. Significant amelioration in superoxide dismutase (SOD) and catalase activities was observed from the 3rd up to the 10th days for lungs, on the 7th and 10th days for kidneys and at 10 days for liver. Data obtained showed that for the different tissues, improvement in the decrease of reduced glutathione (GSH) contents was obvious on the 10th day after irradiation. Treatment with Aloe vera was also effective in minimizing the radiation-induced increase in plasma glucose levels throughout the experimental period, while it has not ameliorated the increase in plasma insulin levels. It could be concluded that the synergistic relationship between the elements found in the leaf of Aloe vera could be a useful adjunct for maintaining the integrity of the antioxidant status.
Asunto(s)
Aloe/química , Antioxidantes/metabolismo , Antioxidantes/efectos de la radiación , Animales , Glucemia/metabolismo , Catalasa/sangre , Dieta , Glutatión/sangre , Insulina/sangre , Riñón/enzimología , Riñón/metabolismo , Riñón/efectos de la radiación , Peroxidación de Lípido/efectos de los fármacos , Peroxidación de Lípido/efectos de la radiación , Hígado/enzimología , Hígado/metabolismo , Hígado/efectos de la radiación , Pulmón/enzimología , Pulmón/metabolismo , Pulmón/efectos de la radiación , Masculino , Ratas , Superóxido Dismutasa/sangre , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Irradiación Corporal TotalRESUMEN
Skilful surgery combined with blood-saving methods and careful management of blood coagulation will all help reduce unnecessary blood loss and transfusion requirements. Excessive surgical bleeding causes hypovolaemia, haemodynamic instability, anaemia and reduced oxygen delivery to tissues, with a subsequent increase in postoperative morbidity and mortality. The role of anaesthetists in managing surgical blood loss has increased greatly in the last decade. Position of the patient during surgery and the provision of a hypotensive anaesthetic regimen were once considered the most important contributions of the anaesthetist to decreasing blood loss. Now, several pharmacological haemostatic agents are being used by anaesthetists as blood-saving agents. After a brief discussion of the physiology of haemostasis, this article will review the evidence for the role of such agents in reducing perioperative blood loss and transfusion requirements.
Asunto(s)
Pérdida de Sangre Quirúrgica/prevención & control , Hemostasis Quirúrgica/métodos , Hemostáticos/uso terapéutico , Antifibrinolíticos/uso terapéutico , Aprotinina/uso terapéutico , Desamino Arginina Vasopresina/uso terapéutico , Factor VIIa/uso terapéutico , Hemostasis/fisiología , Humanos , Proteínas Recombinantes/uso terapéuticoRESUMEN
BACKGROUND: Prostaglandins modulate cytokine release though increases in cAMP, regulating interleukin (IL) 6 and IL-10. Diclofenac inhibits cyclo-oxygenase activity and hence prostaglandin production. We hypothesized that diclofenac would affect release of IL-6 and IL-10 and modulate the immune response. METHODS: In a randomized, double-blind, placebo-controlled study, we investigated the effect of diclofenac in patients undergoing major urological surgery. Patients were randomized to receive either diclofenac (50 mg orally every 8 h the day before surgery and 75 mg i.m. every 12 h on the day of surgery, n = 23) or placebo (n = 23). Standardized combined general anaesthesia and epidural analgesia was administered. Serum IL-6, IL-10 and cortisol were measured before surgery and 30 min and 2, 6, 12 and 24 h after skin incision. Temperature, leucocyte count and C-reactive protein concentration were measured before surgery and after 24 h. RESULTS: IL-6 and IL-10 concentrations increased, reaching peak levels at 12 and 6 h respectively in both groups. At 12 h, the IL-6 concentration was significantly lower in patients receiving diclofenac than in those receiving placebo (P = 0.003). In contrast, IL-10 concentration at 6 h was higher in diclofenac-treated patients (P = 0.008), and this was associated with less pyrexia (P = 0.03), a lower leucocyte count (P = 0.0002) and a lower C-reactive protein concentration (P = 0.0039). Serum cortisol concentration was similar in the two groups of patients until 24 h, when the concentration was lower in patients who received diclofenac (P = 0.002). Cortisol concentration correlated with IL-6 concentration at 24 h. CONCLUSIONS: Administration of diclofenac was associated with lower IL-6 and higher IL-10 concentrations, and lower leucocyte count, C-reactive protein concentration and temperature. Diclofenac may have an anti-inflammatory role in major surgery.
Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Inhibidores de la Ciclooxigenasa/farmacología , Diclofenaco/farmacología , Interleucina-10/sangre , Interleucina-6/sangre , Anciano , Proteína C-Reactiva/efectos de los fármacos , Proteína C-Reactiva/metabolismo , Método Doble Ciego , Femenino , Humanos , Hidrocortisona/sangre , Periodo Intraoperatorio , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Procedimientos Quirúrgicos UrológicosRESUMEN
BACKGROUND: Routine perioperative monitoring with accelero-myography might prevent residual block, whereas routine tactile evaluation of the response to train-of-four (TOF) nerve stimulation does not. The purpose of this prospective, randomised and blinded study was to evaluate the effect of manual evaluation of the response to double burst stimulation (DBS3.3) upon the incidence of residual block. METHODS: Sixty adult patients scheduled for elective abdominal surgery were included in the study. Pancuronium 0.08 to 0.1 mg kg-1 was given for relaxation and tracheal intubation. For maintenance of neuromuscular block, pancuronium 1-2 mg was administered. The patients were randomly allocated into two groups. In group DBS (double burst stimulation) the degree of block during anaesthesia was assessed by manual evaluation of the response to TOF nerve stimulation. During reversal, when no fade was detectable in the TOF response, the stimulation pattern was changed to DBS3.3. The trachea was extubated when the anaesthetist judged the neuromuscular function to have recovered adequately and no fade in the DBS3.3 response could be felt. In group CC (clinical criteria) patients were managed without the use of a nerve stimulator, and the level of neuromuscular block and reversal were evaluated solely on the basis of clinical criteria. In both groups, the TOF ratio was measured by mechanomyography immediately after tracheal extubation. Also, the ability to sustain head lift for 5 s, to protrude the tongue, to open the eyes, and to lift one arm to the opposite shoulder were tested. RESULTS: The TOF ratio, as measured immediately after tracheal extubation, was significantly lower in group CC than in group DBS (means: 0.68 and 0.78, respectively), and the incidence of residual neuromuscular block defined as a TOF ratio < 0.7 was significantly higher in group CC than in group DBS (57 and 24%, respectively). The time from the first TOF measurement until the TOF ratio reached 0.8 was significantly longer in group CC than in group DBs (means: 11.5 and 6.2 min, respectively). No significant differences between the two groups of patients were found in duration of anaesthesia, in times from end of surgery to injection of neostigmine, tracheal extubation or TOF ratio 0.8, in dose of pancuronium, or in any other postoperative variable. CONCLUSION: Routine perioperative manual evaluation of the responses to TOF and DBS3.3 decreased the incidence and the degree of residual block following the use of pancuronium. It did not, however, exclude clinically significant residual paralysis, nor did it influence the amount of pancuronium used during the operation, the duration of anaesthesia or the time from end of surgery to tracheal extubation or to sufficient recovery of neuromuscular function (TOF = 0.8).